Dr. Reddy's Laboratories Limited — Board Meeting, 12-05-2026: Outcome of Board Meeting

Dr. Reddy's reported FY26 consolidated revenue of ₹33,593.3 Cr & PAT of ₹4,285.0 Cr. Q4 PAT: ₹220.1 Cr (impacted by one-offs). Board proposed ₹8/share final dividend, approved two Independent Directors & Deloitte as new Statutory Auditors. #DRREDDY